A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Open accessThe DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index; 20 of the 36 sources its claims cite were checked for support.
Abstract
Oncogene-induced senescence (OIS) is crucial for tumour suppression. Senescent cells implement a complex pro-inflammatory response termed the senescence-associated secretory phenotype (SASP). The SASP reinforces senescence, activates immune surveillance and paradoxically also has pro-tumorigenic properties. Here, we present evidence that the SASP can also induce paracrine senescence in normal cells both in culture and in human and mouse models of OIS in vivo. Coupling quantitative proteomics with small-molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF-β family ligands, VEGF, CCL2 and CCL20. Amongst them, TGF-β ligands play a major role by regulating p15(INK4b) and p21(CIP1). Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling. The inflammasome and IL-1 signalling are activated in senescent cells and IL-1α expression can reproduce SASP activation, resulting in senescence. Our results demonstrate that the SASP can cause paracrine senescence and impact on tumour suppression and senescence in vivo.
Overview
CoChat Summary
## TL;DR
Cells undergoing oncogene-induced senescence (OIS) can transmit senescence to neighboring normal cells through secreted SASP factors, creating a stable paracrine senescence state in culture and in vivo. The paper identifies TGFβ family ligands and IL-1/inflammasome signaling as key regulators of this process.
## Key findings
- Normal IMR90 fibroblasts and HMECs became growth-arrested when co-cultured with OIS cells; the effect was transmitted through transwells and conditioned media, showing it was mediated by soluble factors rather than direct contact.
- Paracrine senescence resembled full senescence: normal cells showed increased DNA/oxidative damage, p16^INK4a^, p21^CIP1^, and SASP markers; gene-expression profiles of OIS and paracrine senescence were highly correlated and clustered together.
- Quantitative proteomics and a 78-compound screen implicated multiple SASP components in paracrine senescence, including TGFβ family ligands, VEGF, CCL2, and CCL20; blocking VEGFR2/FLT3, TGFBR1, or CCR2 partially impaired the arrest.
- The paper reports specific in vivo evidence of paracrine senescence: p21^CIP1^+/p16^INK4a^ cells were found near OIS lesions in mouse liver and skin, and in human serrated sessile adenomas the stromal p21^CIP1^/Ki-67^- signal was significantly increased near lesions (p = 0.03), with a separate comparison reporting p = 4.6 × 10^-5^ for p21^CIP1^ positive/Ki67 negative stromal cells.
## Methods
- Co-culture, transwell, conditioned-media, and cluster assays were used in human IMR90 fibroblasts and HMECs; OIS was induced with ER:RAS, MEK:ER, or related oncogenic constructs activated by 4OHT.
- Secretome analysis used SILAC-based quantitative proteomics, followed by a 78-compound receptor/pathway screen, RNAi knockdown, RT-qPCR, microarrays, GSEA, immunofluorescence/high-content analysis, and assays for BrdU, SA-β-Gal, caspase-1, and antibody arrays.
- In vivo validation used mouse OIS models including Nras-driven hepatocyte senescence, K5-Sos/Egfr^wa2/+^ skin papillomas, and Pdx1-Cre Kras^G12D^ pancreatic lesions, plus human SSA tissue IHC.
## Limitations
- The paper itself notes that “the nature of these cells and the functional implications of paracrine senescence remain open questions for future studies.”
- It also states that not all cells surrounding preneoplastic lesions undergo paracrine senescence; it proposes possible explanations such as soluble-factor gradients and cell-type susceptibility, but these are not experimentally resolved here.
- Evident from the text: many mechanistic and inhibitor results are partial (“partially rescued,” “partially prevented”), so the study does not identify a single exclusive mediator of paracrine senescence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Valid · 1 Not valid · 7 Not checked · 78 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“a transcriptional signature associated with senescence 18 was significantly upregulated during paracrine senescence (Fig 3d).”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence resembles a full senescence response
What the sources say
- Supportedcites [18] Fridman AL, Tainsky MA. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene. 2008; 27:5975-87. [PubMed: 18711403] source
The 'Genomic approaches to identify senescence/immortalization genes and pathways' section describes gene-expression profiling that identifies genes and pathways associated with senescence. In the citing sentence, the citation identifies the senescence-associated transcriptional signature; the finding that it was significantly upregulated during paracrine senescence is attributed to the citing paper’s Fig. 3d, not to this source. No page number is available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Colon SSAs are mainly driven by activating BRAF mutations that trigger OIS 31,34,35 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence is observed in mouse and human models of OIS in vivo
What the sources say
- Partly supportedcites [31] Carragher LA, et al. V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. EMBO Mol Med. 2010; 2:458-71. [PubMed: 20941790] sourceExperimental — accuracy not yet measured
The Discussion reports V600E BRAF mutations in approximately 70% of right-sided serrated hyperplastic polyps and serrated adenomas, supporting a major role for BRAF in the serrated pathway. The Results show that V600E Braf induces senescence in mouse small-intestinal crypts, but do not establish that BRAF mutations trigger OIS in human colon sessile serrated adenomas. (LLM, conf=0.87)
- Partly supportedcites [34] Kriegl L, et al. Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/ adenomas indicates a senescence barrier in the serrated route to colon cancer. Modern Pathology. 2011; 24:1015-22. [PubMed: 21423154] sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says that initiating BRAF mutations might drive oncogene-induced senescence in human serrated polyps, and concludes that the data provide evidence for senescence in the BRAF-mutated serrated route. It does not establish that colon sessile serrated adenomas are mainly driven by BRAF mutations: the study selected BRAF-mutated lesions for its final analysis, and its proposed causal link is hedged. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [35] Bennecke M, et al. Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. Cancer Cell. 2010; 18:135-46. [PubMed: 20708155] source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A signature derived from IMR90 cells undergoing paracrine senescence is found enriched in mouse PANIN 44 and human serrated sessile adenomas (SSA) 36 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > REFERENCES
What the sources say
- Partly supportedcites [44] Ling J, et al. KrasG12D-induced IKK2/beta/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell. 2012; 21:105-20. [PubMed: 22264792] sourceExperimental — accuracy not yet measured
The Results section, “Inhibition of Key Proinflammatory Cytokines,” reports gene-expression profiles from mouse PanIN, so this paper provides the mouse PanIN data cited as reference 44. It does not report testing or finding enrichment of an IMR90 paracrine-senescence signature in those profiles. The SSA finding is attached to a different citation (36), not this source. (LLM, conf=0.79)
- Not checked — no full text of the sourcecites [36] Caruso M, et al. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. Virchows Archiv. 2009; 454:291-302. [PubMed: 19172291] source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
- Also stated in: § Abstract · plain
“Coupling quantitative proteomics with small molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling.”
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
54 more claims
Create a free account to see all 101 claims and every source verdict.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 21
- The quote only partly states this claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The senescent cell fate can be triggered by a number of stressors including DNA damage, cancerous mutations or oncogene activation, mitochondrial dysfunction, reactive metabolites, hyperoxia or hypoxia, proteotoxic stress, extracellular signals, infections, mechanical or shear stresses that deform cells, resistance exercise and factors secreted by other senescent cells18,38–47.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The inflammasome, a multiprotein complex comprising caspase 1 and key regulators of the defence mechanisms against pathogens117, and Toll-like receptors, which regulate the inflammasome, have been reported to promote maturation and secretion of SASP factors during OIS73,118.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, specific SASP components, either soluble or in extracellular vesicles186, can induce senescence in a paracrine manner — which includes DDR activation73,83.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upstream signals triggering SASP activation are multiple and differ depending on the senescence inducer but include DNA damage, cytoplasmic chromatin fragments (CCFs) that trigger a type 1 interferon response, and damage-associated molecular patterns (DAMPs) that activate the inflammasome (Acosta et al., 2013; Davalos et al., 2013; Li and Chen, 2018).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher secretion of SASP factors is also associated with an enhanced immune response, leading to inflammation which may promote tumorigenesis (Acosta et al., 2013).”
From Single senescent cell sequencing reveals heterogeneity in senescent cells induced by telomere erosion (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measured
47 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationPreinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Cited by
Items 201–300 of 2,275
Calcium channel ITPR2 and mitochondria–ER contacts promote cellular senescence and aging
Ziegler, D. V., Vindrieux, D., Goehrig, D., Jaber, S., Collin, G., Griveau, A., Wiel, C., Bendridi, N., Djebali, S., Farfariello, V., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-20993-z · Cited by 194
Proteostasis in cardiac health and disease
Henning, R. H., & Brundel, B. J. J. M. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.89 · Cited by 193
Therapeutic interventions for aging: the case of cellular senescence
Soto-Gamez, A., & Demaria, M. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.01.004 · Cited by 192
Oncogene-induced senescence: a double edged sword in cancer
Liu, X.-L., Ding, J., & Meng, L.-H. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.198 · Cited by 190
Cellular senescence in cancer: from mechanisms to detection
Ou, H., Hoffmann, R., González‐López, C., Doherty, G. J., Korkola, J. E., & Muñoz‐Espín, D. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12807 · Cited by 190
Loss of SATB1 Induces p21-Dependent Cellular Senescence in Post-mitotic Dopaminergic Neurons
Riessland, M., Kolisnyk, B., Kim, T. W., Cheng, J., Ni, J., Pearson, J. A., Park, E. J., Dam, K., Acehan, D., Ramos-Espiritu, L. S., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.08.013 · Cited by 180
“Senescence has an established function in cancer prevention by triggering growth arrest and by signaling to the immune system to remove incipient cancerous cells (Acosta et al., 2013; Acosta et al., 2008; Georgilis et al., 2018; Kang et al., 2011).”
BackgroundGnani, D., Crippa, S., della Volpe, L., Rossella, V., Conti, A., Lettera, E., Rivis, S., Ometti, M., Fraschini, G., Bernardo, M. E., et al. (2019) · Aging Cell · doi:10.1111/acel.12933 · Cited by 188
“…are needed to dissect the role of individual SASP factors secreted by aged MSC on HSPC biology and to determine whether chronic exposure of young HSPC to MSC‐derived inflammatory molecules may induce paracrine senescence in HSPC as previously described in other settings (Acosta et al., 2013).”
ResultThe Skin Microbiome: Current Landscape and Future Opportunities
Smythe, P., & Wilkinson, H. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043950 · Cited by 187
Mensà, E., Guescini, M., Giuliani, A., Bacalini, M. G., Ramini, D., Corleone, G., Ferracin, M., Fulgenzi, G., Graciotti, L., Prattichizzo, F., et al. (2020) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2020.1725285 · Cited by 187
“Overall, SEN sEVs proved capable of modulating apoptosis and a number of key senescence features, i. e. cellular proliferation, SASP acquisition and DNMT1/SIRT1 expression.”
BackgroundInfluentialOgrodnik, M., Salmonowicz, H., & Gladyshev, V. N. (2019) · Aging Cell · doi:10.1111/acel.12841 · Cited by 184
“The bystander effect that induces intracellular damage accumulation in neighboring cells and chronic inflammation leads to tissue dysfunction (Acosta et al., 2013).”
BackgroundJeon, O. H., Wilson, D. R., Clement, C. C., Rathod, S., Cherry, C., Powell, B., Lee, Z., Khalil, A. M., Green, J. J., Campisi, J., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.125019 · Cited by 184
Context-dependent effects of cellular senescence in cancer development.
Lecot, P., Alimirah, F., Desprez, P.-Y., Campisi, J., & Wiley, C. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.115 · Cited by 183
“…order to develop more effective anti-cancer therapies, it might be paramount to understand senescent cells in both their beneficial and pathological contexts, particularly because the SASP can also induce paracrine senescence in normal cells, both in culture and in vivo (Acosta et al, 2013).”
BackgroundHallmarks of aging and immunosenescence: Connecting the dots
Rodrigues, L. P., Teixeira, V. R., Alencar-Silva, T., Simonassi-Paiva, B., Pereira, R. W., Pogue, R., & Carvalho, J. L. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.01.006 · Cited by 184
Liu, P., Li, F., Lin, J., Fukumoto, T., Nacarelli, T., Hao, X., Kossenkov, A. V., Simon, M. C., & Zhang, R. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00656-3 · Cited by 182
Spatial and Temporal Control of Senescence
Ito, Y., Hoare, M., & Narita, M. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.07.004 · Cited by 178
P16INK4A—More Than a Senescence Marker
Safwan-Zaiter, H., Wagner, N., & Wagner, K.-D. (2022) · Life · doi:10.3390/life12091332 · Cited by 181
Melatonin and brain inflammaging
Hardeland, R., Cardinali, D. P., Brown, G. M., & Pandi-Perumal, S. R. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.02.001 · Cited by 181
“In the extreme, ROS and RNS derived by the SASP mechanism can even induce cancer in previously nondamaged cells, in the worst case, in stem cells, which turn into telomerase-expressing cancer stem cells, which are usually not arrested (Davalos et al., 2010; Acosta et al., 2013).”
BackgroundAstrocyte Senescence and Alzheimer’s Disease: A Review
Han, X., Zhang, T., Liu, H., Mi, Y., & Gou, X. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00148 · Cited by 177
“SASPs have been shown to operate as autocrine and paracrine signals to reinforce the senescent state and induce senescence or degenerative changes of the surrounding bystander cells (Coppe et al., 2010; Acosta et al., 2013).”
BackgroundOn the evolution of cellular senescence
Kowald, A., Passos, J. F., & Kirkwood, T. B. L. (2020) · Aging Cell · doi:10.1111/acel.13270 · Cited by 179
“The bystander effect, for instance, describes the fact that the paracrine action of the SASP can convert neighboring cells into new senescent cells (Acosta et al., 2013; Nelson et al., 2012; da Silva et al., 2018; Xu et al., 2017), thus amplifying and spreading the original generation of senescent…”
BackgroundAnti-senescence compounds: A potential nutraceutical approach to healthy aging
Gurău, F., Baldoni, S., Prattichizzo, F., Espinosa, E., Amenta, F., Procopio, A. D., Albertini, M. C., Bonafè, M., & Olivieri, F. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.05.001 · Cited by 179
Reducing Senescent Cell Burden in Aging and Disease
Pignolo, R. J., Passos, J. F., Khosla, S., Tchkonia, T., & Kirkland, J. L. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.03.005 · Cited by 177
Clearance of senescent cells during cardiac ischemia–reperfusion injury improves recovery
Dookun, E., Walaszczyk, A., Redgrave, R., Palmowski, P., Tual‐Chalot, S., Suwana, A., Chapman, J., Jirkovsky, E., Donastorg Sosa, L., Gill, E., et al. (2020) · Aging Cell · doi:10.1111/acel.13249 · Cited by 173
“Furthermore, the SASP can induce senescence in surrounding healthy cells leading to the spreading of senescence throughout affected tissues (Acosta et al., 2013).”
BackgroundRegulation of Survival Networks in Senescent Cells: From Mechanisms to Interventions
Soto-Gamez, A., Quax, W. J., & Demaria, M. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.05.036 · Cited by 175
“Meanwhile, components of the SASP such as IL-6 and IL-8 act in autocrine fashion to reinforce growth arrest through a positive feedback loop [13].”
BackgroundDNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease
Birch, J., Anderson, R. K., Correia-Melo, C., Jurk, D., Hewitt, G., Marques, F. M., Green, N. J., Moisey, E., Birrell, M. A., Belvisi, M. G., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00293.2015 · Cited by 174
Senescence in Wound Repair: Emerging Strategies to Target Chronic Healing Wounds
Wilkinson, H. N., & Hardman, M. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00773 · Cited by 173
Obesity and type-2 diabetes as inducers of premature cellular senescence and ageing
Burton, D. G. A., & Faragher, R. G. A. (2018) · Biogerontology · doi:10.1007/s10522-018-9763-7 · Cited by 173
Cellular senescence and the tumour microenvironment
Takasugi, M., Yoshida, Y., & Ohtani, N. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13268 · Cited by 172
Galactose‐modified duocarmycin prodrugs as senolytics
Guerrero, A., Guiho, R., Herranz, N., Uren, A., Withers, D. J., Martínez‐Barbera, J. P., Tietze, L. F., & Gil, J. (2020) · Aging Cell · doi:10.1111/acel.13133 · Cited by 172
Self-citationSenescence as a therapeutic target in cancer and age-related diseases
McHugh, D., Durán, I., & Gil, J. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01074-4 · Cited by 197
“…DNA damage associated with telomeric attrition 3 , but we now know that multiple other insults, including oncogenic activation 4 , genotoxic stresses 5,6 , exposure to cytokines 7 and virus infection 8 , also cause a persistent activation of the DNA damage response and induce senescence 9 (Fig.”
InfluentialSelf-citationSenescence in Post-Mitotic Cells: A Driver of Aging?
von Zglinicki, T., Wan, T., & Miwa, S. (2021) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8048 · Cited by 170
“The expression of a panel of 36 established SASP genes was investigated by Real Time quantitative polymerase chain reaction (RT-qPCR) on different types of cells isolated from old and young mouse bones (1, 22, 23).”
MethodMitochondria, telomeres and cell senescence: Implications for lung ageing and disease
Birch, J., Barnes, P. J., & Passos, J. F. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.005 · Cited by 170
“Indeed, it has been shown that the SASP can induce senescence in nearby healthy cells, mediated by vascular endothelial growth factor (VEGF), monocyte chemoattractant protein 1 (MCP-1) and CCL20 (Acosta et al., 2013).”
BackgroundSIRT1 suppresses the senescence-associated secretory phenotype through epigenetic gene regulation
Hayakawa, T., Iwai, M., Aoki, S., Takimoto, K., Maruyama, M., Maruyama, W., & Motoyama, N. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116480 · Cited by 170
“Moreover, some SASP components, such as IL-1b, can induce senescence in normal neighboring cells in a paracrine manner [13,14].”
Background“Social Life” of Senescent Cells: What Is SASP and Why Study It?
Borodkina, A. V., Deryabin, P. I., Giukova, А. А., & Nikolsky, N. N. (2018) · Acta Naturae · doi:10.32607/20758251-2018-10-1-4-14 · Cited by 170
Profiling senescent cells in human brains reveals neurons with CDKN2D/p19 and tau neuropathology
Dehkordi, S. K., Walker, J., Sah, E., Bennett, E., Atrian, F., Frost, B., Woost, B., Bennett, R. E., Orr, T. C., Zhou, Y., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00142-3 · Cited by 169
“The gene sets reflected (1) a canonical senescence pathway (CSP) with 22 genes including CDKN2A and CDKN1A that are upregulated in many senescent cell types; (2) 48 genes upregulated early in senescence, which we termed senescence initiating pathway (SIP) and (3) 44 genes Profiling senescent cells in human brains reve…”
BackgroundLau, V., Ramer, L., & Tremblay, M.-È. (2023) · Nature Communications · doi:10.1038/s41467-023-37304-3 · Cited by 167
The emerging role of alternative splicing in senescence and aging
Deschênes, M., & Chabot, B. (2017) · Aging Cell · doi:10.1111/acel.12646 · Cited by 166
Senescent cell turnover slows with age providing an explanation for the Gompertz law
Karin, O., Agrawal, A., Porat, Z., Krizhanovsky, V., & Alon, U. (2019) · Nature Communications · doi:10.1038/s41467-019-13192-4 · Cited by 151
Dynamic Modelling of Pathways to Cellular Senescence Reveals Strategies for Targeted Interventions
Dalle Pezze, P., Nelson, G., Otten, E. G., Korolchuk, V. I., Kirkwood, T. B. L., von Zglinicki, T., & Shanley, D. P. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003728 · Cited by 166
“The same mechanisms generate DNA damage, enhanced ROS production and senescence in somatic bystander cells [12,13].”
BackgroundBlue Journal Conference. Aging and Susceptibility to Lung Disease
Thannickal, V. J., Murthy, M., Balch, W. E., Chandel, N. S., Meiners, S., Eickelberg, O., Selman, M., Pardo, A., White, E. S., Levy, B. D., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1876pp · Cited by 166
“Inflamm-aging may represent part of the spectrum of the senescence-associated secretory phenotype that may exert a profound influence on neighboring cells (97).”
BackgroundYasuda, T., Koiwa, M., Yonemura, A., Miyake, K., Kariya, R., Kubota, S., Yokomizo-Nakano, T., Yasuda-Yoshihara, N., Uchihara, T., Itoyama, R., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108779 · Cited by 165
Kandhaya-Pillai, R., Miro-Mur, F., Alijotas-Reig, J., Tchkonia, T., Kirkland, J. L., & Schwartz, S. (2017) · Aging · doi:10.18632/aging.101328 · Cited by 165
“We hypothesize that, in addition to positive feedforward mechanisms, negative feedback loops also contribute to restrain the SASP network during senescence.”
BackgroundInfluentialCancer cells enter dormancy after cannibalizing mesenchymal stem/stromal cells (MSCs)
Bartosh, T. J., Ullah, M., Zeitouni, S., Beaver, J., & Prockop, D. J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612290113 · Cited by 164
“In opposition to tumor growth, factors associated with the SASP can alert the immune system (61), reinforce the phenotype, and propagate growth arrest signals to surrounding cells (62, 63), implying that senescence programs exert bystander effects (64).”
BackgroundChambers, C. R., Ritchie, S., Pereira, B. A., & Timpson, P. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13042 · Cited by 165
Confalonieri, P., Volpe, M. C., Jacob, J., Maiocchi, S., Salton, F., Ruaro, B., Confalonieri, M., & Braga, L. (2022) · Cells · doi:10.3390/cells11132095 · Cited by 164
“Interestingly, MMP1 and MMP7 are also SASP factors found to be upregulated in the lungs of patients with progressive fibrosis [50,51,54].”
BackgroundDNA damage response (DDR) and senescence: shuttled inflamma-miRNAs on the stage of inflamm-aging
Olivieri, F., Albertini, M. C., Orciani, M., Ceka, A., Cricca, M., Procopio, A. D., & Bonafè, M. (2015) · Oncotarget · doi:10.18632/oncotarget.5899 · Cited by 163
“The SASP components, under the control of the inflammasome, are also able to propagate paracrine senescence to neighboring cells, which become capable of acquiring the SASP phenotype [7].”
BackgroundApolipoprotein D takes center stage in the stress response of the aging and degenerative brain
Dassati, S., Waldner, A., & Schweigreiter, R. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.148 · Cited by 163
Elimination of p19ARF-expressing cells enhances pulmonary function in mice
Hashimoto, M., Asai, A., Kawagishi, H., Mikawa, R., Iwashita, Y., Kanayama, K., Sugimoto, K., Sato, T., Maruyama, M., & Sugimoto, M. (2016) · JCI Insight · doi:10.1172/jci.insight.87732 · Cited by 162
“The contribution of senescent cells in aging-associated phenotypes may depend on their non–cellautonomous functions, such as senescence-associated secretory phenotype (SASP), because the population of senescent cells is very small, even in very old human tissue (10).”
BackgroundInfluentialParacrine cellular senescence exacerbates biliary injury and impairs regeneration
Ferreira-Gonzalez, S., Lu, W.-Y., Raven, A., Dwyer, B., Man, T. Y., O’Duibhir, E., Lewis, P. J. S., Campana, L., Kendall, T. J., Bird, T. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03299-5 · Cited by 161
Self-citationThe Senescence-Associated Secretory Phenotype: Critical Effector in Skin Cancer and Aging
Ghosh, K., & Capell, B. C. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.06.621 · Cited by 160
“In studies performed in both foreskin fibroblasts and mammary epithelial cells, IL1α has been shown to be an upstream regulator of other SASP factors during oncogene-induced senescence, including IL6, IL8, vascular endothelial growth factor, and transforming growth factor-β (Acosta et al., 2013; Orjalo et al., 2009).”
BackgroundMitochondria: Are they causal players in cellular senescence?
Correia-Melo, C., & Passos, J. F. (2015) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2015.05.017 · Cited by 160
“Passos,Mitochondria: Are the 17 Both the senescence-associated pro-oxidant and pro-inflammatory phenotypes have been shown to not only stabilise senescence in an autocrine fashion [2,59,90], but also to induce paracrine senescence which may contribute to the detrimental effects of senescence during ageing [1,85].”
BackgroundCellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies
Lucas, V., Cavadas, C., & Aveleira, C. A. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000622 · Cited by 160
Prattichizzo, F., De Nigris, V., Mancuso, E., Spiga, R., Giuliani, A., Matacchione, G., Lazzarini, R., Marcheselli, F., Recchioni, R., Testa, R., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2017.12.001 · Cited by 159
Ageing induced vascular smooth muscle cell senescence in atherosclerosis
Uryga, A. K., & Bennett, M. R. (2016) · The Journal of Physiology · doi:10.1113/jp270923 · Cited by 160
“In addition, senescent cells reinforce their phenotype to non-senescent neighbouring cells via autocrine and paracrine effects (Acosta et al. 2008, 2013; van Deursen, 2014), which may promote atherosclerosis.”
BackgroundVascular smooth muscle cell senescence and age-related diseases: State of the art
Chi, C., Li, D.-J., Jiang, Y.-J., Tong, J., Fu, H., Wu, Y.-H., & Shen, F.-M. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.015 · Cited by 158
Hwang, H. J., Lee, Y.-R., Kang, D., Lee, H. C., Seo, H. R., Ryu, J.-K., Kim, Y.-N., Ko, Y.-G., Park, H. J., & Lee, J.-S. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.06.019 · Cited by 157
Similarities and interplay between senescent cells and macrophages
Behmoaras, J., & Gil, J. (2021) · Journal of Cell Biology · doi:10.1083/jcb.202010162 · Cited by 158
“We have shown that cells undergoing oncogene-induced senescence secreted and processed mature forms of IL-1α and IL-1β, suggesting inflammasome activation preceding SASP (Acosta et al., 2013).”
BackgroundSelf-citationZhang, B., Fu, D., Xu, Q., Cong, X., Wu, C., Zhong, X., Ma, Y., Lv, Z., Chen, F., Han, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04010-4 · Cited by 157
Cell Senescence, DNA Damage, and Metabolism
Shmulevich, R., & Krizhanovsky, V. (2021) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8043 · Cited by 157
“Since SASP may cause both beneficial and harmful consequences, it may thus serve as a potent, dual-edged target for human disease pharmaceutical intervention (2, 74).”
Rejuvenating Strategies for Stem Cell-Based Therapies in Aging
Neves, J., Sousa-Victor, P., & Jasper, H. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.01.008 · Cited by 156
“The SASP can further contribute to age-related tissue dysfunction through the paracrine induction of secondary senescence in healthy neighboring cells (Acosta et al., 2013; Nelson et al., 2012).”
Faces of cellular senescence in skin aging
Ho, C. Y., & Dreesen, O. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111525 · Cited by 158
“senescence trigger, species and cell type (Aird and Zhang, 2013).”
BackgroundMLL1 is essential for the senescence-associated secretory phenotype
Capell, B. C., Drake, A. M., Zhu, J., Shah, P. P., Dou, Z., Dorsey, J., Simola, D. F., Donahue, G., Sammons, M., Rai, T. S., et al. (2016) · Genes & Development · doi:10.1101/gad.271882.115 · Cited by 156
Rossiello, F., Herbig, U., Longhese, M. P., Fumagalli, M., & d’Adda di Fagagna, F. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2014.06.009 · Cited by 156
Cellular Senescence and the Biology of Aging, Disease, and Frailty
LeBrasseur, N. K., Tchkonia, T., & Kirkland, J. L. (2015) · Nestlé Nutrition Institute Workshop Series · doi:10.1159/000382054 · Cited by 147
The innate immune sensor Toll-like receptor 2 controls the senescence-associated secretory phenotype
Hari, P., Millar, F. R., Tarrats, N., Birch, J., Quintanilla, A., Rink, C. J., Fernández-Duran, I., Muir, M., Finch, A. J., Brunton, V. G., et al. (2019) · Science Advances · doi:10.1126/sciadv.aaw0254 · Cited by 154
Self-citationOxidative stress, cellular senescence and ageing
Pole, A., Department of Biochemistry and Molecular Medicine, S. O. M. A. H. S., Dimri, M., & P. Dimri, G. (2016) · AIMS Molecular Science · doi:10.3934/molsci.2016.3.300 · Cited by 155
“The SASP factors mediate pro-oncogenic effects of senescence via cell non-autonomous mechanisms which involve a paracrine signaling [83,96,165].”
BackgroundHallmarks of progeroid syndromes: lessons from mice and reprogrammed cells
Carrero, D., Soria-Valles, C., & López-Otín, C. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.024711 · Cited by 153
“This phenomenon is mainly regulated by NF-κ B (Acosta et al., 2013; Chien et al., 2011).”
COVID-19 and cellular senescence
Schmitt, C. A., Tchkonia, T., Niedernhofer, L. J., Robbins, P. D., Kirkland, J. L., & Lee, S. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00785-2 · Cited by 153
Brandenberger, C., & Mühlfeld, C. (2017) · Cell and Tissue Research · doi:10.1007/s00441-016-2511-x · Cited by 152
Cardiac fibroblasts regulate the development of heart failure via Htra3-TGF-β-IGFBP7 axis
Ko, T., Nomura, S., Yamada, S., Fujita, K., Fujita, T., Satoh, M., Oka, C., Katoh, M., Ito, M., Katagiri, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30630-y · Cited by 176
Cellular senescence impact on immune cell fate and function
Vicente, R., Mausset-Bonnefont, A.-L., Jorgensen, C., Louis-Plence, P., & Brondello, J.-M. (2016) · Aging Cell · doi:10.1111/acel.12455 · Cited by 151
“Although senescence can be eventually propagated from cell to cell by a bystander effect (Acosta et al., 2013), the mechanism underlying the suppressive effect of senescent T cells remains largely unknown.”
BackgroundGeng, Q., Gao, H., Yang, R., Guo, K., & Miao, D. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.25783 · Cited by 150
“The SASP not only has harmful paracrine effects but also has systemic effects [49-51].”
BackgroundImmunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases
Bleve, A., Motta, F., Durante, B., Pandolfo, C., Selmi, C., & Sica, A. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08909-7 · Cited by 153
“Of note, MDSCs secrete the anti-inflammatory cytokine TGFβ which is a potent inducer of cellular senescence in inflamed tissues [87].”
BackgroundExtracellular matrix alterations in senescent cells and their significance in tissue homeostasis
Mavrogonatou, E., Pratsinis, H., Papadopoulou, A., Karamanos, N. K., & Kletsas, D. (2019) · Matrix Biology · doi:10.1016/j.matbio.2017.10.004 · Cited by 153
Notch Signaling Mediates Secondary Senescence
Teo, Y. V., Rattanavirotkul, N., Olova, N., Salzano, A., Quintanilla, A., Tarrats, N., Kiourtis, C., Müller, M., Green, A. R., Adams, P. D., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.104 · Cited by 149
“Paracrine senescence is thought to be the main effector mechanism for secondary, cell extrinsic senescence induction (Acosta et al., 2013; Kuilman et al., 2008).”
BackgroundMethodInfluentialSelf-citationThe role of cellular senescence and SASP in tumour microenvironment
Takasugi, M., Yoshida, Y., Hara, E., & Ohtani, N. (2023) · The FEBS Journal · doi:10.1111/febs.16381 · Cited by 144
Whole Chromosome Instability induces senescence and promotes SASP
Andriani, G. A., Almeida, V. P., Faggioli, F., Mauro, M., Tsai, W. L., Santambrogio, L., Maslov, A., Gadina, M., Campisi, J., Vijg, J., et al. (2016) · Scientific Reports · doi:10.1038/srep35218 · Cited by 146
“…of growth arrest in an autocrine feedback loop (CXCL8, CXCL1, IL6) 1 , paracrine induction of senescence in bystander normal cells (CCL2, IL1B) 71,72 , promotion of epithelial-mesenchyme transitions and invasiveness (CXCL8, IL6) 48 , stimulation of angiogenesis (CCL2, CSF2, CXCL12) 2,73 , tumor…”
Senescence as a therapeutically relevant response to CDK4/6 inhibitors
Wagner, V., & Gil, J. (2020) · Oncogene · doi:10.1038/s41388-020-1354-9 · Cited by 148
Self-citationAging and chronic inflammation: highlights from a multidisciplinary workshop
Saavedra, D., Añé-Kourí, A. L., Barzilai, N., Caruso, C., Cho, K., Fontana, L., Franceschi, C., Frasca, D., Ledón, N., Niedernhofer, L. J., et al. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00352-w · Cited by 168
mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance
Garros-Regulez, L., Aldaz, P., Arrizabalaga, O., Moncho-Amor, V., Carrasco‐García, E., Manterola, L., Moreno‐Cugnon, L., Barrena, C., Villanúa, J., Ruiz, I., et al. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1151002 · Cited by 151
“This impairment in shSOX2 cell proliferation was accompanied by a significant increase in senescence measured by cytoplasmic β-galactosidase activity and IL1α, interleukin associated to senescence-associated secretory phenotype [32] both elevated by more than 2.”
BackgroundImmunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment
McQuitty, C. E., Williams, R., Chokshi, S., & Urbani, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.574276 · Cited by 146
Wang, B., Wang, L., Gasek, N. S., Zhou, Y., Kim, T., Guo, C., Jellison, E. R., Haynes, L., Yadav, S., Tchkonia, T., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00107-6 · Cited by 145
Cellular senescence in musculoskeletal homeostasis, diseases, and regeneration
Wan, M., Gray-Gaillard, E. F., & Elisseeff, J. H. (2021) · Bone Research · doi:10.1038/s41413-021-00164-y · Cited by 165
“Not only do SnCs with SASP induce autocrine reinforcement, but they also communicate with neighboring cells in a paracrine manner to propagate the stress response in the tissue microenvironment.(56,61,62) Of note, the paracrine effects of the SASP can be beneficial or detrimental depending on the tissue context.”
BackgroundThe multifaceted role of the SASP in atherosclerosis: from mechanisms to therapeutic opportunities
Sun, Y., Wang, X., Liu, T., Zhu, X., & Pan, X. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00815-5 · Cited by 168
Biomarkers to identify and isolate senescent cells
Matjusaitis, M., Chin, G., Sarnoski, E. A., & Stolzing, A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.003 · Cited by 144
“Multiple studies have validated SASP and its related factors as robust markers of senescence, which makes them very promising candidates (Acosta et al., 2013; Sandeman et al., 2001).”
Single-cell senescence identification reveals senescence heterogeneity, trajectory, and modulators
Tao, W., Yu, Z., & Han, J.-D. J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.03.009 · Cited by 147
Experimental Models of Sarcopenia: Bridging Molecular Mechanism and Therapeutic Strategy
Mankhong, S., Kim, S., Moon, S., Kwak, H., Park, D., & Kang, J. (2020) · Cells · doi:10.3390/cells9061385 · Cited by 162
“For example, oncogene-induced senescence produces SASP, which can, in turn, recruit the immune system for tumor clearance and eventual tumor regression [21]; however, SASP can also promote tumorigenesis [22].”
BackgroundSILAC Analysis Reveals Increased Secretion of Hemostasis-Related Factors by Senescent Cells
Wiley, C. D., Liu, S., Limbad, C., Zawadzka, A. M., Beck, J., Demaria, M., Artwood, R., Alimirah, F., Lopez-Dominguez, J.-A., Kuehnemann, C., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.049 · Cited by 137
“Validation of SILACs Results in Cultured Cells To validate the SILAC results, we collected CM from three independent cultures of quiescent or IR-induced senescent HCA2 cells and determined by western blotting the levels of 11 hemostasis-related factors identified by SILACs (Figure 1D).”
BackgroundMethodInfluentialSpatial mapping of cellular senescence: emerging challenges and opportunities
Gurkar, A. U., Gerencser, A. A., Mora, A. L., Nelson, A. C., Zhang, A. R., Lagnado, A. B., Enninful, A., Benz, C., Furman, D., Beaulieu, D., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00446-6 · Cited by 141
The Role of Curcumin in the Modulation of Ageing
Bielak-Zmijewska, A., Grabowska, W., Ciolko, A., Bojko, A., Mosieniak, G., Bijoch, Ł., & Sikora, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051239 · Cited by 140
“By co-culturing senescent cells with normal cells, it was shown that the senescent phenotype could be transmitted to surrounding cells via soluble SASP proteins [104].”
BackgroundCyclin G1 and TASCC regulate kidney epithelial cell G 2 -M arrest and fibrotic maladaptive repair
Canaud, G., Brooks, C. R., Kishi, S., Taguchi, K., Nishimura, K., Magassa, S., Scott, A., Hsiao, L.-L., Ichimura, T., Terzi, F., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav4754 · Cited by 139
“These results are in accordance with recent findings showing that the senescence of one cell can be transmitted by secretory paracrine mechanisms to neighboring cells (37).”
ResultSenescent cells communicate via intercellular protein transfer
Biran, A., Perelmutter, M., Gal, H., Burton, D. G. A., Ovadya, Y., Vadai, E., Geiger, T., & Krizhanovsky, V. (2015) · Genes & Development · doi:10.1101/gad.259341.115 · Cited by 139
“The prevailing view of how senescent cells facilitate changes within their microenvironment has primarily been focused on secreted factors acting in a paracrine manner (Freund et al. 2010; Kuilman et al. 2010; Acosta et al. 2013; Burton and Krizhanovsky 2014).”
Guo, Y., Ayers, J. L., Carter, K. T., Wang, T., Maden, S. K., Edmond, D., Newcomb P, P., Li, C., Ulrich, C., Yu, M., et al. (2019) · Aging Cell · doi:10.1111/acel.13013 · Cited by 139
“…tissues, such as prostate and breast, through the senescence‐associated secretory phenotype (SASP), which is characterized by the increased expression of cytokines, chemok‐ ines, growth factors, and proteases (Acosta et al, 2013; Brenner et al., 2007; de Jager et al., 2011; Fray & Dickinson, 2001).”
BackgroundGene expression profiling of replicative and induced senescence
Purcell, M., Kruger, A., & Tainsky, M. A. (2014) · Cell Cycle · doi:10.4161/15384101.2014.973327 · Cited by 132
“This up-regulation of inflammatory factors during aging could be the cause of the senescence-associated secretory phenotype, which causes a secretion of inflammatory factors to the surrounding environment leading to bystander senescence of nearby cells or even transformation of nearby pre-malignant cells.(30) However,…”
BackgroundGeroconversion: irreversible step to cellular senescence
Blagosklonny, M. V. (2014) · Cell Cycle · doi:10.4161/15384101.2014.985507 · Cited by 138
“Paracrine geroconversion also takes place.(115,116) Gradually geroconversion involves most cells in diverse tissues.”
BackgroundLozano-Torres, B., Estepa-Fernández, A., Rovira, M., Orzáez, M., Serrano, M., Martínez-Máñez, R., & Sancenón, F. (2019) · Nature Reviews Chemistry · doi:10.1038/s41570-019-0108-0 · Cited by 140
The role of adipose tissue senescence in obesity- and ageing-related metabolic disorders
Liu, Z., Wu, K. K. L., Jiang, X., Xu, A., & Cheng, K. K. Y. (2020) · Clinical Science · doi:10.1042/cs20190966 · Cited by 137
Curcumin and o-Vanillin Exhibit Evidence of Senolytic Activity in Human IVD Cells In Vitro
Cherif, H., Bisson, D., Jarzem, P., Weber, M., Ouellet, J., & Haglund, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040433 · Cited by 136
“Furthermore, it can, in a paracrine manner, induce senescence, which further intensifies tissue deterioration [6].”
BackgroundMechanisms of NLRP3 priming in inflammaging and age related diseases
Gritsenko, A., Green, J., Brough, D., & López‐Castejón, G. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.08.003 · Cited by 153
“Additionally, caspase-1 inhibition partially inhibited cell cycle arrest, whilst IL-1R1 inhibition did so fully, suggesting that IL-1 β plays a role in reinforcing senescence and also highlights the role of IL-1 α [56].”
BackgroundSenescence and the tumor-immune landscape: Implications for cancer immunotherapy
Chibaya, L., Snyder, J. T., & Ruscetti, M. A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.005 · Cited by 161
The role of cellular senescence in skin aging and age-related skin pathologies
Chin, T., Lee, X. E., Ng, P. Y., Lee, Y., & Dreesen, O. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1297637 · Cited by 138
Metadata
- Authors
- Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., Pascual, G., Morris, K. J., Khan, S., Jin, H., Dharmalingam, G., Snijders, A. P., Carroll, T., Capper, D., Pritchard, C., Inman, G. J., Longerich, T., Sansom, O. J., Benitah, S. A., Zender, L., & Gil, J.
- Affiliations
- Imperial College London (GB)
- Centre for Genomic Regulation (ES)
- Cancer Research UK Scotland Institute (GB)
- University of Tübingen (DE)
- German Cancer Research Center (DE)
- University of Leicester (GB)
- University of Dundee (GB)
- Corresponding author
- Gil, Jesús
- ORCID
- Acosta, Juan Carlos
- Banito, Ana
- Janich, Peggy
- Morton, Jennifer P.
- Athineos, Dimitris
- Lasitschka, Felix
- Andrulis, Mindaugas
- Pascual, Gloria
- Khan, Sadaf
- Jin, Hong
- Snijders, Ambrosius P.
- Carroll, Thomas
- Capper, David
- Pritchard, Catrin
- Inman, Gareth J.
- Longerich, Thomas
- Sansom, Owen J.
- Benitah, Salvador Aznar
- Zender, Lars
- Gil, Jesús
- Venue
- Nature Cell Biology
- Published
- 2013-06-16
- Volume
- 15
- Issue
- 8
- Pages
- 978-990
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC3732483
- OpenAlex
- W2140930678
- Semantic Scholar
- 59786bed7ce43f9317328cd82838f14d911e5dd4
- Cited by
- 2,278
- References
- 54
- Citations by year
- 2026: 247 · 2025: 225 · 2024: 232 · 2023: 240 · 2022: 264 · 2021: 250 · 2020: 202 · 2019: 154 · 2018: 119 · 2017: 107 · 2016: 89 · 2015: 79 · 2014: 56 · 2013: 13
- FWCI
- 54.88
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-04-28)
- Open access
- green
- europepmc.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- NERC Open Research Archive (Natural Environment Research Council) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (acceptedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Cancer Research UK (A7769, 13083, 11650, 12481)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- oncogene-induced senescence, senescence-associated secretory phenotype, paracrine senescence, inflammasome, IL-1 signaling, TGF-beta ligands, vascular endothelial growth factor, MCP-1, CCL20, CDKN2B, p21, tumor suppression, senescence-associated secretome
- MeSH terms
- Animals, Colonic Neoplasms, Humans, Immunohistochemistry, Interleukin-1, Protein Binding, Signal Transduction, Gene Expression Regulation, Neoplastic, Cellular Senescence, Paracrine Communication, Models, Animal, Cell Line, Tumor, Mice, Transforming Growth Factor beta1, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.